Mode of action of oral hypoglycaemic agents. II. Sulphonylureas & biguanides in rats.
D000092:Acetohexamide / Q000494:pharmacology; D000284:Administration, Oral; D000324:Adrenocorticotropic Hormone / Q000037:antagonists & inhibitors; D000818:Animals; D050260:Carbohydrate Metabolism; D002747:Chlorpropamide / Q000494:pharmacology; D003864:Depression, Chemical; D004791:Enzyme Inhibitors; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005947:Glucose / Q000378:metabolism; D005952:Glucose-6-Phosphatase / Q000378:metabolism; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D007535:Isomerases / Q000378:metabolism; D008071:Lipoprotein Lipase / Q000378:metabolism; D008660:Metabolism / Q000187:drug effects; D009132:Muscles / Q000201:enzymology* / Q000378:metabolism; D010629:Phenformin / Q000494:pharmacology*; D006005:Phosphorylases / Q000378:metabolism; D051381:Rats; D013268:Stimulation, Chemical; D013453:Sulfonylurea Compounds / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology; D014306:Trioses
D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D014306:Trioses; D000324:Adrenocorticotropic Hormone; D014044:Tolbutamide; D010629:Phenformin; D005954:Glucosephosphate Dehydrogenase; D006005:Phosphorylases; D008071:Lipoprotein Lipase; D005952:Glucose-6-Phosphatase; D007535:Isomerases; D005947:Glucose; D000092:Acetohexamide; D002747:Chlorpropamide; D004837:Epinephrine